"Misonidazole" is a descriptor in the National Library of Medicine's controlled vocabulary thesaurus,
MeSH (Medical Subject Headings). Descriptors are arranged in a hierarchical structure,
which enables searching at various levels of specificity.
A nitroimidazole that sensitizes normally radio-resistant hypoxic cells to radiation. It may also be directly cytotoxic to hypoxic cells and has been proposed as an antineoplastic.
Descriptor ID |
D008920
|
MeSH Number(s) |
D02.640.672.530 D03.383.129.308.658.530
|
Concept/Terms |
Misonidazole- Misonidazole
- alpha-(Methoxymethyl)-2-nitro-1H-imidazole-1-ethanol
Ro 07-0582- Ro 07-0582
- Ro 07 0582
- Ro 070582
- Ro 7-0582
- Ro 7 0582
- Ro 70582
|
Below are MeSH descriptors whose meaning is more general than "Misonidazole".
Below are MeSH descriptors whose meaning is more specific than "Misonidazole".
This graph shows the total number of publications written about "Misonidazole" by people in this website by year, and whether "Misonidazole" was a major or minor topic of these publications.
To see the data from this visualization as text,
click here.
Year | Major Topic | Minor Topic | Total |
---|
2019 | 0 | 1 | 1 |
To return to the timeline,
click here.
Below are the most recent publications written about "Misonidazole" by people in Profiles.
-
Buparlisib with thoracic radiotherapy and its effect on tumour hypoxia: A phase I study in patients with advanced non-small cell lung carcinoma. Eur J Cancer. 2019 05; 113:87-95.
-
Hydroxyurea versus misonidazole with radiation in cervical carcinoma: long-term follow-up of a Gynecologic Oncology Group trial. J Clin Oncol. 1993 Aug; 11(8):1523-8.
-
A randomized trial of hydroxyurea versus misonidazole adjunct to radiation therapy in carcinoma of the cervix. A preliminary report of a Gynecologic Oncology Group study. Am J Obstet Gynecol. 1988 Jul; 159(1):87-94.